Hydrocortisone Hemisuccinate Anhydrous

CHEMBL977 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
462.5 g/mol
LogP
1.8
Phase
4

A hemisuccinate anhydrous form of hydrocortisone with the same therapeutic properties. A synthetic form of the naturally occurring glucocorticoid cortisol, used to treat a wide range of inflammatory and allergic conditions including asthma, eczema, rheumatoid arthritis, and adrenal insufficiency by suppressing immune and inflammatory responses.

Moleküler Ağırlık

462,5000 g/mol

LogP

1,80

TPSA

138,00 Ų

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O

InChI

InChI=1S/C25H34O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30)/t16-,17-,18-,22+,23-,24-,25-/m0/s1

Molecular Formula

C25H34O8

HBD / HBA

3 / 8

Döndürülebilir Bağlar

7

Ağır Atomlar

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A hemisuccinate anhydrous form of hydrocortisone with the same therapeutic properties. A synthetic form of the naturally occurring glucocorticoid cortisol, used to treat a wide range of inflammatory and allergic conditions including asthma, eczema, rheumatoid arthritis, and adrenal insufficiency by suppressing immune and inflammatory responses.

Yes, Hydrocortisone Hemisuccinate Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL977. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 16623. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.